← Back
$TNGX All transactions

Tango Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

12,000

Price

$0

Filed

Mar 27

Insider

Name

Crystal Adam

Title

President, R&D

CIK

0001825445

Roles

Officer

Transaction Details

Transaction Date

2026-03-25

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

460,500

Footnotes

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.27, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Filing Info

Accession No.

0001193125-26-129990

Form Type

4

Issuer CIK

0001819133

Crystal Adam's History

Date Ticker Type Value
2026-04-15 TNGX M $200K
2026-04-15 TNGX $962K
2026-04-15 TNGX M $0
2026-04-01 TNGX M $140K
2026-04-01 TNGX $572K
2026-04-01 TNGX M $0
2026-03-25 TNGX M $62K
2026-03-25 TNGX $241K
2026-03-25 TNGX M $0
2026-03-05 TNGX $304K

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$127K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$3.0M 2026-04-15